Lipid mediators in immune dysfunction after severe inflammation.

Fullerton, James N; O'Brien, Alastair J; Gilroy, Derek W

Fullerton, James N; O'Brien, Alastair J; Gilroy, Derek W.

Affiliation

Fullerton JN; Centre for Clinical Pharmacology, Division of Medicine, Rayne Institute, 5 University Street, University College London, London, WC1E 6JF, UK. Electronic address: james.fullerton@doctors.org.uk.
O'Brien AJ; Centre for Clinical Pharmacology, Division of Medicine, Rayne Institute, 5 University Street, University College London, London, WC1E 6JF, UK.
Gilroy DW; Centre for Clinical Pharmacology, Division of Medicine, Rayne Institute, 5 University Street, University College London, London, WC1E 6JF, UK.

Trends Immunol ; 35(1): 12-21, 2014 Jan.

Article in En | MEDLINE | ID: mdl-24268519

Subject(s)

Inflammation Mediators/metabolism; Inflammation/immunology; Inflammation/metabolism; Lipid Metabolism/immunology; Animals; Critical Illness; Humans; Inflammation/etiology; Inflammation/therapy; Signal Transduction

Key words

cyclooxygenase; eicosanoids; immunosuppression; prostaglandins; resolution of inflammation; sepsis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammation Mediators / Lipid Metabolism / Inflammation Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Trends Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google